Clinical Trial Detail

NCT ID NCT02663908
Title A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Recruitment Active, not recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Ferring Pharmaceuticals
Indications

prostate cancer

Therapies

Degarelix

Leuprolide

Age Groups: adult

No variant requirements are available.